Xenon Pharmaceuticals(XENE)
BC - BurnabyPharmaceutical
Focus: Xenon Pharmaceuticals is a public biotech company focused on small-molecule therapeutics for rare genetic diseases, particularly in neurology and seizure disorders. The company is pre-commercial with a lean operational footprint and a concentrated pipeline in neurology.
Profile data last refreshed 6h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
29+2 this month
Stable — net +2 jobs in 30d
11 added, 9 removed. Backfill posture.
Should You Work at Xenon Pharmaceuticals?
AI assessmentXenon is a high-risk, high-reward opportunity for professionals seeking early-stage exposure to late-phase pipeline catalysts in neurology, but clinical trial outcomes over the next 12-24 months will determine long-term career stability.
Why Work Here
- Strong Phase 3 pipeline with 11 active Phase 3 programs (XEN496, XEN1101, Azetukalner) addressing high-unmet-need indications in epilepsy, seizure disorders, and depression
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
11 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Pipeline & Clinical Trials
XEN901
Healthy VolunteersClinical Trials (1)
NCT03467100Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901
Phase 1Help build intelligence for Xenon Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.